Benzinga | Oct 28, 2021 09:30AM EDT

Rosenblatt Maintains Sell on CME Group, Raises Price Target to $197

Rosenblatt analyst Sean Horgan maintains CME Group (NASDAQ:CME) with a Sell and raises the price target from $194 to $197.